MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

bluebird bio Company Profile (NASDAQ:BLUE)

Consensus Ratings for bluebird bio (NASDAQ:BLUE) (?)
Ratings Breakdown: 4 Hold Rating(s), 13 Buy Rating(s)
Consensus Rating:Buy (Score: 2.76)
Consensus Price Target: $112.07 (152.52% upside)

Analysts' Ratings History for bluebird bio (NASDAQ:BLUE)
Show:
DateFirmActionRatingPrice TargetActions
5/11/2016Piper JaffrayReiterated RatingBuy$117.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Janney Montgomery ScottReiterated RatingBuy$91.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2016Jefferies GroupReiterated RatingBuy$84.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2016BTIG ResearchReiterated RatingBuy$72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Wells FargoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016WedbushReiterated RatingOutperform$117.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2016Goldman SachsReiterated RatingNeutral$149.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016Maxim GroupReiterated RatingBuy$105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/5/2016Leerink SwannReiterated RatingOutperform$67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2016Roth CapitalReiterated RatingNeutral$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015JPMorgan Chase & Co.DowngradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Bank of AmericaDowngradeBuy -> Neutral$149.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Morgan StanleyDowngradeOverweight -> Equal Weight$143.00 -> $69.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/16/2015Cowen and CompanyReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015OppenheimerReiterated RatingOutperform$162.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2015BMO Capital MarketsInitiated CoverageBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015SunTrustReiterated RatingBuy$205.00 -> $230.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha